<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01045499</url>
  </required_header>
  <id_info>
    <org_study_id>AAAB1759</org_study_id>
    <nct_id>NCT01045499</nct_id>
  </id_info>
  <brief_title>LAGB as a Treatment for Morbid Obesity in Adolescents</brief_title>
  <official_title>Laparoscopic Adjustable Gastric Banding (LAGB) as a Treatment for Morbid Obesity in Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jeffrey L Zitsman, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic adjustable gastric banding (LAGB) has been used worldwide to help selected
      morbidly obese adults to lose weight. The FDA has approved LAGB only for patients 18 years or
      older. Our hypothesis that LAGB can be used to assist selected adolescents between 14 and 17
      years lose weight and that the procedure can be performed safely in this age group. We are
      also evaluating the effects of weight loss after LAGB on known comorbid conditions such as
      sleep apnea syndrome and insulin resistance, and also on psychological health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Seventy to ninety-eight percent of obese children become obese adults. Comorbidities of
      obesity such as type II diabetes, fatty liver disease, hyperlipidemia, hypertension, asthma,
      sleep apnea, and depression are becoming increasing common in adolescents as more adolescents
      become obese. The only consistently durable and effective weight loss programs for the
      morbidly obese patients are those that include bariatric surgical procedures. The
      investigators believe that the best initial bariatric surgical option for adolescents is LAGB
      because of its low complication rates, adjustability, and reversibility. Obese adolescents
      ages 14-17 who meet criteria for entry will be enrolled to determine the degree of success of
      LAGB as measured by % excess weight loss, decreased % body fat, decreased body mass index
      (BMI), reduction in comorbid conditions, and metabolic parameters (including serum lipids and
      glucose tolerance) at intervals of 3 months, 6 months, 1 year, then annually for a total of 5
      years postoperatively. Eligible patients will have been followed for 6 months by physicians
      in the Center for Adolescent Bariatric Surgery and: 1) will attended a minimum of 75% of
      visits and 2) will have failed to lose at least 20% of excess weight. Following evaluation by
      the team (which will include evaluations by a nutritionist, an endocrinologist, a
      psychologist/psychiatrist, a pediatric nurse practitioner, and a surgeon) a patient may be
      offered LAGB.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 13, 2005</start_date>
  <completion_date type="Actual">April 30, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Excess Weight Change (EWL)</measure>
    <time_frame>Baseline and up to 5 years from start of study.</time_frame>
    <description>Weight change evaluated in terms of % excess weight loss (EWL).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Excess BMI Change</measure>
    <time_frame>Baseline and up to 5 years from start of study.</time_frame>
    <description>Change in Body mass index (BMI) in terms of excess BMI loss (EBMIL).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">137</enrollment>
  <condition>Morbid Obesity</condition>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Insulin Resistance</condition>
  <condition>Nonalcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>laparoscopic gastric banding</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adolescent patients who have undergone laparoscopic adjustable gastric banding. Weight, BMI, and co-morbidity data will be compared to patient's pre-operative values.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic adjustable gastric banding (Allergan Lap Band)</intervention_name>
    <description>Pre-op evaluation, surgical placement of a gastric band, and follow-up for a minimum of 5 years after surgery. Surgery is laparoscopic adjustable gastric band placement using a single brand of gastric band. Evaluations before and after surgery include but are not limited to history and physical examination, serum chemistry studies, imaging, sleep studies, and pulmonary function testing.</description>
    <arm_group_label>laparoscopic gastric banding</arm_group_label>
    <other_name>LAP-BANDÂ®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 13-17 upon entry

          -  BMI &gt;40 or &gt;35 with associated medical comorbidities (e.g., sleep apnea, hypertension

        Exclusion Criteria:

          -  severe psychiatric illness

          -  eating disorder with purging

          -  previous weight loss surgery

          -  stated inability to comply with pre-op and post-op visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey L Zitsman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Morgan Stanley Children's Hospital of NY Presbyterian</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 7, 2010</study_first_submitted>
  <study_first_submitted_qc>January 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2010</study_first_posted>
  <results_first_submitted>March 17, 2020</results_first_submitted>
  <results_first_submitted_qc>April 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 13, 2020</results_first_posted>
  <last_update_submitted>April 1, 2020</last_update_submitted>
  <last_update_submitted_qc>April 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Jeffrey L Zitsman, MD</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>adolescent obesity surgery</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>adjustable gastric banding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Adolescents aged 13 to 18 years were enrolled in this study.</recruitment_details>
      <pre_assignment_details>The age range for the enrolled adolescents at the time of surgery was 14-19 years of age since some aged from the time of consent to surgery.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Laparoscopic Gastric Banding</title>
          <description>Adolescent patients who have undergone laparoscopic adjustable gastric banding. Weight, BMI, and co-morbidity data will be compared to patient's pre-operative values.
Laparoscopic adjustable gastric banding (Allergan Lap Band): Pre-op evaluation, surgical placement of a gastric band, and follow-up for a minimum of 5 years after surgery. Surgery is laparoscopic adjustable gastric band placement using a single brand of gastric band. Evaluations before and after surgery include but are not limited to history and physical examination, serum chemistry studies, imaging, sleep studies, and pulmonary function testing.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="137"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>adolescents with morbid obesity 14-18yr</population>
      <group_list>
        <group group_id="B1">
          <title>Adolescents With Morbid Obesity</title>
          <description>At the time of enrollment, the adolescents with morbid obesity were aged 13-18 years of age and at the time of surgery, the adolescents were aged 14-19 years of age.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="137"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.0" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Family obesity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Mother</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Father</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Both</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes (not identified)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neither</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adopted (no information)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Excess Weight Change (EWL)</title>
        <description>Weight change evaluated in terms of % excess weight loss (EWL).</description>
        <time_frame>Baseline and up to 5 years from start of study.</time_frame>
        <population>Includes individuals with confirmed band status at 5 years after surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Laparoscopic Gastric Banding</title>
            <description>Adolescent patients who have undergone laparoscopic adjustable gastric banding. Weight, BMI, and co-morbidity data will be compared to patient's pre-operative values.
Laparoscopic adjustable gastric banding (Allergan Lap Band): Pre-op evaluation, surgical placement of a gastric band, and follow-up for a minimum of 5 years after surgery. Surgery is laparoscopic adjustable gastric band placement using a single brand of gastric band. Evaluations before and after surgery include but are not limited to history and physical examination, serum chemistry studies, imaging, sleep studies, and pulmonary function testing.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Excess Weight Change (EWL)</title>
          <description>Weight change evaluated in terms of % excess weight loss (EWL).</description>
          <population>Includes individuals with confirmed band status at 5 years after surgery.</population>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-35.5" spread="39.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Excess BMI Change</title>
        <description>Change in Body mass index (BMI) in terms of excess BMI loss (EBMIL).</description>
        <time_frame>Baseline and up to 5 years from start of study.</time_frame>
        <population>Includes individuals with confirmed band status at 5 years after surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Laparoscopic Gastric Banding</title>
            <description>Adolescent patients who have undergone laparoscopic adjustable gastric banding. Weight, BMI, and co-morbidity data will be compared to patient's pre-operative values.
Laparoscopic adjustable gastric banding (Allergan Lap Band): Pre-op evaluation, surgical placement of a gastric band, and follow-up for a minimum of 5 years after surgery. Surgery is laparoscopic adjustable gastric band placement using a single brand of gastric band. Evaluations before and after surgery include but are not limited to history and physical examination, serum chemistry studies, imaging, sleep studies, and pulmonary function testing.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Excess BMI Change</title>
          <description>Change in Body mass index (BMI) in terms of excess BMI loss (EBMIL).</description>
          <population>Includes individuals with confirmed band status at 5 years after surgery.</population>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6" spread="37.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were recorded as perioperative if occurring less than or equal to 30 days following surgery and post-operative if greater than 30 days. Safety data was collected up to 5 years post-surgery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Laparoscopic Gastric Banding</title>
          <description>Adolescent patients who have undergone laparoscopic adjustable gastric banding. Weight, BMI, and co-morbidity data will be compared to patient's pre-operative values.
Laparoscopic adjustable gastric banding (Allergan Lap Band): Pre-op evaluation, surgical placement of a gastric band, and follow-up for a minimum of 5 years after surgery. Surgery is laparoscopic adjustable gastric band placement using a single brand of gastric band. Evaluations before and after surgery include but are not limited to history and physical examination, serum chemistry studies, imaging, sleep studies, and pulmonary function testing.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="63" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Band removal due to dysphagia, reflux or heartburn</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Hiatal hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Gastric Herniation (band slippage)</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Port site bleeding</sub_title>
                <description>Resulted in surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Malpositioned band</sub_title>
                <description>Resulted in surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <description>Resulted in surgery.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Port displacement</sub_title>
                <description>Resulted in operative port repositioning.</description>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Band removal</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Weight loss procedure (conversion)</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="137" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Emesis</sub_title>
                <counts group_id="E1" events="266" subjects_affected="96" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="114" subjects_affected="62" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>GERD/Heartburn</sub_title>
                <counts group_id="E1" events="68" subjects_affected="44" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="25" subjects_affected="18" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Port site pain</sub_title>
                <counts group_id="E1" events="73" subjects_affected="46" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Headaches</sub_title>
                <counts group_id="E1" events="16" subjects_affected="14" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Sore throat</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Elevated CES-D Score</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Knee pain</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Esophageal dilation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory infection (URI)</sub_title>
                <counts group_id="E1" events="40" subjects_affected="32" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia/food stuck</sub_title>
                <counts group_id="E1" events="76" subjects_affected="40" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Band slip/prolapse</sub_title>
                <counts group_id="E1" events="14" subjects_affected="10" subjects_at_risk="137"/>
              </event>
              <event>
                <sub_title>Port displacement/flip</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="137"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeffrey Zitsman, MD</name_or_title>
      <organization>Columbia University</organization>
      <phone>212-305-8862</phone>
      <email>jlz2@cumc.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

